Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • TAR76
    Junior Member
    • Jun 2015
    • 2

    #1

    FDR Correction before gene ontology analysis

    Hi,

    I am analysing some RNA-seq data. I get a gene list of differentially expressed genes with around 100 DE genes if the FDR value, rather than the raw P-value, is used.

    When using this list of differentially expressed genes for gene set enrichment analysis should I be using the FDR values from the differentially expressed genes or the raw P values +/- a log fold change cut off.

    I am thinking that it should be the FDR values from my differentially expressed genes but I have come across a few published papers in my field that have used a P-value and a log fold change cut off (although when I go back through the data from these studies they have very few differentially expressed genes by FDR so perhaps this is the reason).

    Would be interested in your opinions on this.
    Thanks.

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    10-30-2026, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
33 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
21 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
72 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...